194 related articles for article (PubMed ID: 29748372)
1. TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.
Wang Q; Gao G; Zhang T; Yao K; Chen H; Park MH; Yamamoto H; Wang K; Ma W; Malakhova M; Bode AM; Dong Z
Cancer Res; 2018 Jul; 78(14):3982-3994. PubMed ID: 29748372
[TBL] [Abstract][Full Text] [Related]
2. TNF receptor-associated factor 1 as a biomarker for assessment of non-small cell lung cancer metastasis and overall survival.
Wen X; Wang B; Feng T; Yuan W; Zhou J; Fang T
Clin Respir J; 2018 Jul; 12(7):2197-2203. PubMed ID: 29528567
[TBL] [Abstract][Full Text] [Related]
3. ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.
Li Y; Ye Z; Chen S; Pan Z; Zhou Q; Li YZ; Shuai WD; Kuang CM; Peng QH; Shi W; Mao X; Liu RY; Huang W
Int J Cancer; 2018 Apr; 142(7):1379-1391. PubMed ID: 29164615
[TBL] [Abstract][Full Text] [Related]
4. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
[TBL] [Abstract][Full Text] [Related]
5. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.
Sughra K; Birbach A; de Martin R; Schmid JA
PLoS One; 2010 Sep; 5(9):e12683. PubMed ID: 20856938
[TBL] [Abstract][Full Text] [Related]
8. TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.
Yamamoto H; Ryu J; Min E; Oi N; Bai R; Zykova TA; Yu DH; Moriyama K; Bode AM; Dong Z
J Invest Dermatol; 2017 Jun; 137(6):1322-1332. PubMed ID: 28131816
[TBL] [Abstract][Full Text] [Related]
9. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
[TBL] [Abstract][Full Text] [Related]
10. CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs.
Zapata JM; Perez-Chacon G; Carr-Baena P; Martinez-Forero I; Azpilikueta A; Otano I; Melero I
Front Immunol; 2018; 9():2618. PubMed ID: 30524423
[TBL] [Abstract][Full Text] [Related]
11. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
12. Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway.
Wang X; Wang Q; Hu W; Evers BM
Oncogene; 2004 Mar; 23(10):1885-95. PubMed ID: 14981539
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
Zheng C; Kabaleeswaran V; Wang Y; Cheng G; Wu H
Mol Cell; 2010 Apr; 38(1):101-13. PubMed ID: 20385093
[TBL] [Abstract][Full Text] [Related]
14. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
Pearson LL; Castle BE; Kehry MR
Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
[TBL] [Abstract][Full Text] [Related]
15. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.
Li K; Zheng X; Tang H; Zang YS; Zeng C; Liu X; Shen Y; Pang Y; Wang S; Xie F; Lu X; Luo Y; Li Z; Bi W; Jia X; Huang T; Wei R; Huang K; Chen Z; Zhu Q; He Y; Zhang M; Gu Z; Xiao Y; Zhang X; Fletcher JA; Wang Y
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34143182
[TBL] [Abstract][Full Text] [Related]
16. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
17. Non-canonical Raf-1/p70S6K signalling in non-small-cell lung cancer.
Qiu Z; Ye B; Zhao S; Li X; Li L; Mo X; Li W
J Cell Mol Med; 2019 Nov; 23(11):7632-7640. PubMed ID: 31541523
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
[TBL] [Abstract][Full Text] [Related]
19. Targeting Opsin4/Melanopsin with a Novel Small Molecule Suppresses PKC/RAF/MEK/ERK Signaling and Inhibits Lung Adenocarcinoma Progression.
Wang Q; Zhang T; Chang X; Wang K; Lee MH; Ma WY; Liu K; Dong Z
Mol Cancer Res; 2020 Jul; 18(7):1028-1038. PubMed ID: 32269074
[TBL] [Abstract][Full Text] [Related]
20. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
